| Dr Jesse Singer, DO | |
|
7305 N Military Trl, Primary Care (110), Riviera Beach, FL 33410-7417 | |
| (561) 422-7577 | |
| (561) 422-7615 |
| Full Name | Dr Jesse Singer |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 7305 N Military Trl, Riviera Beach, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982623302 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | OS8324 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jesse Singer, DO 610 Clematis St, Apt 332, West Palm Beach, FL 33401-5398 Ph: (561) 422-7577 | Dr Jesse Singer, DO 7305 N Military Trl, Primary Care (110), Riviera Beach, FL 33410-7417 Ph: (561) 422-7577 |
News Archive
The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $200,000 grant from Purdue Pharma L.P. today at the organization's 27th annual conference in Charleston, South Carolina. The grant is part of Purdue Pharma's ongoing efforts to support the operation, expansion and awareness of appropriately-designed state prescription drug monitoring programs, which can be an effective tool to address prescription drug abuse and diversion.
September is Muscular Dystrophy Awareness Month. There are more than 100 neuromuscular disorders and it is estimated more than 50,000 Canadians are affected by one form or another. Each form is caused by an error in a specific gene related to muscle function.
Correctly and quickly diagnosing malaria is essential for effective and life-saving treatment. But rapid detection, particularly in remote areas, is not always possible because current methods are time-consuming and require precise instrumentation and highly skilled microscopic analysis. Now, a promising new optical imaging system, described in a paper published today in the Optical Society's (OSA) open-access journal Biomedical Optics Express, may make the diagnosis of this deadly disease much easier, faster, and more accurate.
An examination of the treatment received by patients with myocardial infarction (heart attack) at 80 hospitals in Quebec indicates that those who received either primary percutaneous coronary intervention (PPCI; such as angioplasty) or fibrinolysis (administration of medication to dissolve blood clots) beyond the times recommended in international guidelines had a significantly increased risk of death within 30 days, along with an increased risk of the combined outcome of death or readmission for heart attack or heart failure at one year, according to a study in the June 2 issue of JAMA.
Lung cancer remains the leading cause of cancer deaths in the U.S., with half of those diagnosed at age 70 years or older. About 20 percent of patients with lung cancer will have small cell lung cancer (SCLC). In the past, SCLC progressed rapidly despite initial chemotherapy sensitivity and few patients survive three years.
› Verified 7 days ago
Dr. Kingsley Ndubisi Anurugwo, MD Preventive Medicine Medicare: May Accept Medicare Assignments Practice Location: 851 Avenue P, Riviera Beach, FL 33404 Phone: 561-803-7300 Fax: 561-840-0168 | |
Dr. Judith Marie Majewski, MD,MPH, Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 7289 Garden Rd, Riviera Beach, FL 33404 Phone: 561-804-7900 | |
Dr. Savita Kumar, MD, MSPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 7289 Garden Rd, Riviera Beach, FL 33404 Phone: 561-804-7865 |